CB06-036

· Shanghai Zhimeng Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CB06-036, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB06-036 in Subjects With Chronic Hepatitis B [Phase 1]

See pricing